Scarica l'app Stockscreener
325.00
0.01%
-0.03
Dopo l'orario di chiusura:
325.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Insulet Corporation Borsa (PODD) Ultime notizie
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Rating - MSN
Goldman Sachs Initiates Coverage of Insulet (BIT:1PODD) with Buy Recommendation - Nasdaq
Insulet (NASDAQ:PODD) Now Covered by The Goldman Sachs Group - Defense World
Goldman Sachs starts Insulet stock with buy, $380 target By Investing.com - Investing.com Canada
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Recommendation - Nasdaq
Goldman Sachs Initiates Coverage on Insulet (PODD) with a Buy Ra - GuruFocus
Goldman Sachs Initiates Coverage on Insulet (PODD) with Buy Rati - GuruFocus
Goldman Sachs Initiates Coverage on Insulet (PODD) with Buy Rating | PODD Stock News - GuruFocus
Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy - Investing.com
Goldman Sachs Initiates Insulet at Buy With $380 Price Target - marketscreener.com
Goldman Sachs starts Insulet stock with buy, $380 target - Investing.com
Goldman Sachs Starts Insulet Corporation (PODD) at Buy - StreetInsider
Insulet (NASDAQ:PODD) Upgraded by Wall Street Zen to “Buy” Rating - Defense World
Goldman Sachs Initiates Coverage on Insulet (PODD) with Positive Outlook | PODD Stock News - GuruFocus
Insulet initiated with a Buy at Goldman Sachs - TipRanks
Questions About High-Flying Insulet Corp. - Law Street Media
Insulet Corporation (PODD) Announces Approval of 2025 Stock Opti - GuruFocus
Insulet Corporation: Shares Remain Astronomically Expensive (NASDAQ:PODD) - Seeking Alpha
Insulet Corporation Holds 2025 Annual Stockholders Meeting - TipRanks
Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own? - Yahoo Finance
What Is Insulet Corporation's (NASDAQ:PODD) Share Price Doing? - simplywall.st
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga
Raymond James Increases Price Target for Insulet (PODD) to $360 - GuruFocus
Insulet (NASDAQ:PODD) Price Target Raised to $360.00 at Raymond James - Defense World
Insulet Gains 78.5% in a Year: What's Driving the Stock? - MSN
Insulet (PODD) Target Price Raised by Raymond James | PODD Stock News - GuruFocus
Raymond James Increases Price Target for Insulet (PODD) to $360 | PODD Stock News - GuruFocus
Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating - marketscreener.com
Insulet stock target lifted to $360 by Raymond James - Investing.com India
Insulet Corporation (PODD) PT Raised to $360 at Raymond James - StreetInsider
Cetera Investment Advisers Has $631,000 Position in Insulet Co. (NASDAQ:PODD) - Defense World
(PODD) Technical Data - news.stocktradersdaily.com
Insulet Foe Rips $30M Atty Fee Ask As 'Over-Lawyered' - Law360
Insulet to Present at the Goldman Sachs 46th Annual Global Healt - GuruFocus
Do Wall Street Analysts Like Insulet Stock? - MSN
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - Eagle-Tribune
Analysts Turn Bullish on Insulet Stock (PODD) after Strong Q1 Earnings - MSN
5 Analysts Assess Insulet: What You Need To KnowInsulet (NASDAQ:PODD) - Benzinga
Insulet (PODD) Price Target Raised by Citigroup to $380 | PODD Stock News - GuruFocus
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance
Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating - marketscreener.com
Citi adds Edwards Lifesciences stock as Top Pick, drops Insulet - Investing.com
Global Insulin Pumps Market Report 2021-2030: Insulet, - openPR.com
Insulet stock soars to 52-week high, reaches $326.53 By Investing.com - Investing.com South Africa
Insulet stock soars to 52-week high, reaches $326.53 - Investing.com
Captrust Financial Advisors Raises Stake in Insulet Co. (NASDAQ:PODD) - Defense World
Here's What to Expect From Insulet's Next Earnings Report - MSN
Insulet Adds Stryker Executive to Board - Medical Product Outsourcing
Insulet Creates Medical Director Position - Medical Product Outsourcing
Insulet stock price target raised to $375 by Bernstein - Investing.com Australia
'Insulet Corporation (PODD) is Our Top Pick in Diabetes'; PT Raised to $375 at Bernstein - StreetInsider
Here's Why Insulet (PODD) is a Strong Momentum Stock - Yahoo Finance
Bernstein Boosts Insulet (PODD) Price Target Amid Strong Market Position | PODD Stock News - GuruFocus
Insulet’s SVP Cashes In: A Multi-Million Dollar Stock Sale! - TipRanks
1.28%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):